UBE2N and acute lymphoblastic leukemia: Furthermore, in acute lymphoblastic leukemia models, UBE2N may be a key node of oncogenic immune signaling, as blocking its mediated ubiquitination of innate immune molecules can inhibit its oncogenic function (68).